OBI Received a Civil Complaint from Taiwan Shilin District Court
Parties to the legal matter: Plaintiff: Securities and Futures Investors Protection Center (SFIPC) Defendant: OBI Pharma, Inc. and Dr. Michael N. Chang (Chairman) Name of the legal agency or court:...
View ArticleAnnouncement on Change of the Head of Finance and Accounting
Type of personnel changed (please enter: spokesperson, acting spokesperson, important personnel(CEO, COO, CMO, CSO, etc.),financial officer, accounting officer, research and development officer, or...
View ArticleAnnouncement on Change of the Acting Spokesperson
Type of personnel changed (please enter: spokesperson, acting spokesperson, important personnel(CEO, COO, CMO, CSO, etc.),financial officer, accounting officer, research and development officer, or...
View ArticleContract Signing with Pharmacore for the Contract Manufacturing of OBI-858
Date of occurrence: September 25, 2017 Contract or the other party to the contract: PharmaCore Biotech Co., Ltd Relationship to the Company (please enter ”head office” or ”affiliated company”): None...
View ArticleUSPTO Approved the Patent Application for OBI-888 “Antibodies, pharmaceutical...
Date of occurrence: October 6, 2017 Company name: OBI Pharma Inc. Relationship to the Company (please enter ”head office” or ”affiliated company”): head office Reciprocal shareholding ratios: N/A...
View ArticleAnnouncement on Change of the Accounting Officer
Type of personnel changed (please enter: spokesperson, acting spokesperson, important personnel(CEO, COO, CMO, CSO, etc.),financial officer, accounting officer, research and development officer, or...
View ArticleOBI Plans to Issue New Shares in Exchange for the AP Biosciences, Inc. Shares...
Please visit Investor Announcement page for more detail.
View ArticleSFIPC and OBI jointly agreed to withdraw the proceedings on Civil case...
Parties to the legal matter: Plaintiff: Securities and Futures Investors Protection Center (SFIPC) Defendant: OBI Pharma, Inc. and Dr. Michael N. Chang (Chairman) Name of the legal agency or court:...
View ArticleOBI Pharma Inc. to attend the 2017 Asia Pacific Healthcare Forum, hosted by...
Date: November 29, 2017 1.Date of the event: Nov 29–Nov 30, 2017 2.Time: 09:00:00 CST 3.Location：Jw Marriott Hotel Hong Kong Level 3 Ballroom 4.Summary: OBI Pharma Inc. to attend the 2017 Asia Pacific...
View ArticleOBI Pharma Inc. to attend Citi’s 2017 Global Healthcare Conference
Date: Dec 06, 2017 1. Date of the event: Dec 06–Dec 07, 2017 2. Time: 21:30:00 EST 3. Location：The Lotte New York Palace, New York USA 4. Summary: OBI Pharma Inc. to attend the Citi’s 2017 Global...
View ArticleOBI Pharma Inc. to attend the 36th J.P. Morgan Annual Healthcare Conference
Date: Dec 22, 2017 1. Date of the event: Jan 09–Jan 11, 2018 2. Time: 01:00:00 EST 3. Location: Westin St. Francis Hotel, San Francisco, CA USA 4. Summary: OBI Pharma Inc. to attend the 36th J.P....
View ArticleCapital increase for new shares to transfer to ABPROTIX INC.
Type of merger/acquisition (e.g. merger, consolidation, spin-off,acquisition, or receiving assignment of shares): Receiving assignment of shares Date of occurrence of the event: Dec 29, 2017 Names of...
View ArticleOBI Pharma Inc. to attend the investor conference on new drug development,...
Date: January 16, 2018 1.Date of the event: Jan 16, 2018 2.Time: 14:00:00 (Taiwan Time) 3.Location：Courtyard Marriott Taipei 4.Summary: OBI Pharma Inc. to attend the investor conference on new drug...
View ArticleShilin District Court deny OBI’s request to submit the case for trial
Defendant: Reporter Pei amongst the other six reporters Name of the legal agency or court: Taiwan Shilin District Court Reference/case numbers of relevant documents: 2017 Sheng Pan Zi, No. 72 Date of...
View ArticleFDA CLEARANCE OF IND APPLICATION FOR A PHASE 1 STUDY OF A MONOCLONAL ANTIBODY...
Date of occurrence of the event: January 17, 2018 Company name: OBI Pharma, Inc. Relationship to the Company (please enter ”head office” or ”affiliated company”): Head office Reciprocal shareholding...
View ArticleClarification on the news articles by Commercial Times, United Daily, etc.
Date of occurrence of the event:2018/02/23 Company name: OBI Pharma, Inc. Relationship to the Company (please enter ”head office” or ”affiliated company”): N/A Reciprocal shareholding ratios: N/A Name...
View ArticleThe Board of Directors resolved to hold 2018 Annual General Meeting
Date of events: Mar 09, 2018 Contents: Date of the board of directors resolution: Mar 09, 2018 Date for convening the shareholders’ meeting: Jun 27, 2018 Location for convening the shareholders’...
View ArticleThe board of directors have resolved 2017 not to distribute dividends
Date of events:2018/03/09 Contents: Date of the board of directors resolution: 2018/03/09 Appropriations of earnings in cash dividends to shareholders (NT$ per share):0 Cash dividends distributed from...
View ArticleOBI Pharma’s Board of Directors approves the announcement of the Company’s...
Date of events: 2018/03/09 Contents: 1.Date of occurrence of the event: 2018/03/09 2.Company name: OBI Pharma, Inc 3.Relationship to the Company (please enter “head office” or “subsidiaries”):Parent...
View ArticleAnnouncement on the Change of Chief Financial Officer
Date of events: Mar 09, 2018 Contents: Type of personnel changed (please enter: spokesperson, acting spokesperson, important operational officer, financial officer, accounting officer, research and...
View Article
